Monte Rosa Therapeutics, Inc. (GLUE)
NASDAQ · Healthcare
Monte Rosa Therapeutics, Inc. Net Margin 2023–2025
Current and historical net profit margin for Monte Rosa Therapeutics, Inc. (GLUE) over the last 10 years. The current net profit margin for Monte Rosa Therapeutics, Inc. as of December 31, 2025 is -31.23%.
From: 12/31/2023To: 12/31/2025
Revenue
Net Income
Net Margin
Monte Rosa Therapeutics, Inc. Net Margin — FAQ
Monte Rosa Therapeutics, Inc. (GLUE) net margin over the last 3 years — annual and quarterly figures with year-over-year growth and charts.
What is Monte Rosa Therapeutics, Inc.'s net margin?
Monte Rosa Therapeutics, Inc. (GLUE) reported net margin of -31.2% for fiscal 2025.
Where can I see GLUE's net margin history?
The chart and table above show Monte Rosa Therapeutics, Inc.'s net margin by year and by quarter, including the growth rate.